本页面由Tiger Trade Technology Pte. Ltd.提供服务

Guardant Health Inc.

162.79
-4.6800-2.79%
盘后:162.790.00000.00%16:10 EDT
成交量:150.18万
成交额:2.43亿
市值:218.46亿
市盈率:-46.46
高:168.69
开:168.26
低:158.46
收:167.47
52周最高:191.05
52周最低:61.00
股本:1.34亿
流通股本:1.30亿
量比:0.72
换手率:1.16%
股息:- -
股息率:- -
每股收益(TTM):-3.5037
每股收益(LYR):-3.3203
净资产收益率:-4584.47%
总资产收益率:-18.07%
市净率:-98.02
市盈率(LYR):-49.03

数据加载中...

2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/30

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/30

重要事件披露

Form 8-K - Current report
2026/07/29

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities